Related Experiment Video
Updated: Mar 6, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
Checkpoint-based immunotherapy for autoimmune diseases - Opportunities and challenges
Xiao-Song He1, M Eric Gershwin1, Aftab A Ansari2
1Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, United States.
Immune checkpoint pathways regulate T cell responses, but their dysregulation causes autoimmune diseases. Checkpoint-based immunotherapy offers a promising strategy for restoring T cell tolerance, but requires organ-specific targeting.
Area of Science:
- Immunology
- Autoimmunity
- Cancer Immunology
Background:
- Immune checkpoint pathways are crucial for T cell regulation, balancing host defense and self-tolerance.
- Dysregulation of these pathways can lead to cancer, infections, or autoimmune diseases.
- Current treatments for autoimmune diseases have limited efficacy.
More Related Videos
10:10Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Tumor Immunotherapy
Cell-mediated Immune Responses
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...